COX-2/sEH dual inhibitor PTUPB suppresses glioblastoma growth by targeting epidermal growth factor receptor and hyaluronan mediated motility receptor

AIMS: Cyclooxygenase-2 (COX-2)/soluble epoxide hydrolase (sEH) dual inhibitor, PTUPB, has been demonstrated to inhibit angiogenesis, primary tumor growth and metastasis. The aim of this study is to investigate the effects of PTUPB on glioblastoma cells and xenograft model. RESULTS: We show here that...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junyang, Zhou, Yali, Wang, Handong, Gao, Yongyue, Li, Liwen, Hwang, Sung Hee, Ji, Xiangjun, Hammock, Bruce D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675638/
https://www.ncbi.nlm.nih.gov/pubmed/29152086
http://dx.doi.org/10.18632/oncotarget.20928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675638/
https://www.ncbi.nlm.nih.gov/pubmed/29152086
http://dx.doi.org/10.18632/oncotarget.20928

Ejemplares similares